These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34229855)

  • 21. [Single center comparative analysis of hematopoietic cell transplantation from alternated donor in patients with hematologic malignancies].
    Wang J; Zhou J; Zheng HF; Wang PF; Fu CC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):159-65. PubMed ID: 25687066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of graft-versus-host disease-free, relapse-free survival of transplantation using matched sibling donor, matched unrelated donor or unrelated cord blood after myeloablative conditioning for adult patients with hematological malignancies.
    Konuma T; Kato S; Oiwa-Monna M; Ishii H; Tojo A; Takahashi S
    Leuk Lymphoma; 2016 Sep; 57(9):2126-32. PubMed ID: 26769297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT.
    Schmidt-Hieber M; Tridello G; Ljungman P; Mikulska M; Knelange N; Blaise D; Socié G; Volin L; Blijlevens N; Fegueux N; Yakoub-Agha I; Forcade E; Maertens J; Chevallier P; Passweg J; Cornelissen J; Russell N; Craddock C; Bourhis JH; Marchand T; Reményi P; Cahn JY; Michallet M; Montoto S; Kröger N; Glaß B; Styczynski J
    Ann Hematol; 2019 Jul; 98(7):1755-1763. PubMed ID: 30993417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico.
    Orti G; Sanz J; Bermudez A; Caballero D; Martinez C; Sierra J; Cabrera Marin JR; Espigado I; Solano C; Ferrà C; García-Noblejas A; Jimenez S; Sampol A; Yañez L; García-Gutiérrez V; Pascual MJ; Jurado M; Moraleda JM; Valcarcel D; Sanz MA; Carreras E; Duarte RF
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):584-8. PubMed ID: 26631751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ethics of hematopoietic stem cell donation by minors.
    Ross LF
    Arch Pediatr Adolesc Med; 2009 Nov; 163(11):1065; author reply 1065-6. PubMed ID: 19884600
    [No Abstract]   [Full Text] [Related]  

  • 26. Informed consent--suggested procedures for informed consent for unrelated haematopoietic stem cell donors at various stages of recruitment, donor evaluation, and donor workup.
    Rosenmayr A; Hartwell L; Egeland T;
    Bone Marrow Transplant; 2003 Apr; 31(7):539-45. PubMed ID: 12692618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using related donors other than genotypically HLA-matched siblings in allogeneic hematopoietic stem cell transplantation for hematologic disease: a single institution experience in Japan.
    Tomonari A; Iseki T; Ooi J; Takahashi S; Ishii K; Takahashi T; Shindo M; Nagamura F; Uchimaru K; Nagayama H; Shirafuji N; Tojo A; Tani K; Asano S
    Int J Hematol; 2002 Nov; 76(4):354-9. PubMed ID: 12463600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sibling cord blood donor program for hematopoietic cell transplantation: the 20-year experience in the Rome Cord Blood Bank.
    Screnci M; Murgi E; Valle V; Tamburini A; Pellegrini MG; Strano S; Corona F; Ambrogi EB; Girelli G
    Blood Cells Mol Dis; 2016 Mar; 57():71-3. PubMed ID: 26852659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor.
    Rovó A; Daikeler T; Halter J; Heim D; Tsakiris DA; Stern M; Waltimo T; Studt JD; Tyndall A; Gratwohl A; Tichelli A
    Haematologica; 2011 Jan; 96(1):150-5. PubMed ID: 20851864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues.
    Worel N; Buser A; Greinix HT; Hägglund H; Navarro W; Pulsipher MA; Nicoloso de Faveri G; Bengtsson M; Billen A; Espino G; Fechter M; Giudice V; Hölig K; Kanamori H; Kodera Y; Leitner G; Netelenbos T; Niederwieser D; van Walraven SM; Rocha V; Torosian T; Vergueiro C; Weisdorf D; Yabe H; Halter JP
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2052-2060. PubMed ID: 26271194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matched unrelated donor transplants-State of the art in the 21st century.
    Altaf SY; Apperley JF; Olavarria E
    Semin Hematol; 2016 Oct; 53(4):221-229. PubMed ID: 27788759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.
    Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
    Ann Hematol; 2021 Jun; 100(6):1579-1591. PubMed ID: 33236196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-β1 functional polymorphisms in myeloablative sibling hematopoietic stem cell transplantation.
    Berro M; Palau Nagore MV; Rivas MM; Longo P; Foncuberta C; Vitriú A; Remaggi G; Martínez Rolon J; Jaimovich G; Requejo A; Feldman L; Padros K; Rodríguez MB; Shaw BE; Larripa I; Belli CB; Kusminsky GD
    Bone Marrow Transplant; 2017 May; 52(5):739-744. PubMed ID: 28134923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers to conceiving sibling donors for sickle cell disease: perspectives from patients and parents.
    Jae GA; Lewkowitz AK; Yang JC; Shen L; Rahman A; Del Toro G
    Ethn Health; 2011; 16(4-5):431-45. PubMed ID: 21797728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased availability of family donors for hematopoietic stem cell transplantation in a population with increased incidence of consanguinity.
    Balcı YI; Tavil B; Tan CS; Ozgur TT; Bulum B; Cetin M; Balcı M; Yalcın S; Tezcan I; Uckan D
    Clin Transplant; 2011; 25(3):475-80. PubMed ID: 20636407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of donor and recipient characteristics on graft-versus-host disease and survival in HLA-matched sibling hematopoietic stem cell transplantation.
    Zhang H
    Transfus Apher Sci; 2020 Jun; 59(3):102743. PubMed ID: 32139282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haploidentical Transplantation with Post-Transplant Cyclophosphamide versus Unrelated Donor Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Arcuri LJ; Aguiar MTM; Ribeiro AAF; Pacheco AGF
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2422-2430. PubMed ID: 31386903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells.
    Chen YB; Le-Rademacher J; Brazauskas R; Kiefer DM; Hamadani M; DiPersio JF; Litzow MR; Craig M; Horwitz ME; Artz AS; McClune BL; Fernandez HF; Duong HK; Kobusingye H; Proue M; Drexler RJ; Horowitz MM; Shaw BE; Miller JP; Hosoba S; Waller EK; Devine SM
    Blood Adv; 2019 Mar; 3(6):875-883. PubMed ID: 30890544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [General and ethical considerations for the informed consent process: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Thibert JB; Polomeni A; Yakoub-Agha I; Bordessoule D
    Bull Cancer; 2016 Nov; 103(11S):S207-S212. PubMed ID: 27855949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Themes reported by families as important when proceeding with pediatric hematopoietic stem cell transplantation.
    Pelletier W; Hinds PS; Alderfer MA; Fairclough DL; Stegenga K; Pentz RD
    Pediatr Blood Cancer; 2014 Sep; 61(9):1625-31. PubMed ID: 24798514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.